Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seppo W Langer

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Acta Oncologica (Stockholm, Sweden)|July 31, 2015
Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the artElizaveta Mitkina Tabaksblat, Seppo W Langer, Ulrich Knigge, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2006
PET/CT imaging in response evaluation of patients with small cell lung cancerBarbara M Fischer, Jann Mortensen, Seppo W Langer, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PETMathias Loft, Camilla B Johnbeck, Esben A Carlsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2023
Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomideAnnika Marie Ørting, Malene Martini Clausen, Patrick Soldath, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2024
Clinico-pathological characteristics and treatment outcome in non-small cell lung cancer in Greenland 2015-2020 - a comparison with the cohort from 2004 to 2010Dorte S Nørøxe, Simone Frandsen, Malene M Clausen, et al.
Surgical Oncology|March 1, 2022
Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinomaPatrick Soldath, Tina Binderup, Frederik Carstensen, et al.
Molecular Pharmacology|April 19, 2002
Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibitionLars H Jensen, Axelle Renodon-Corniere, Irene Wessel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive ScansEsben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, et al.
Cancers|February 10, 2024
Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical CarcinoidsPatrick Soldath, Daniel Bianchi, Beatrice Manfredini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Head-to-Head Comparison of <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine TumorsCamilla B Johnbeck, Ulrich Knigge, Annika Loft, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|July 31, 2015
Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the artElizaveta Mitkina Tabaksblat, Seppo W Langer, Ulrich Knigge, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2006
PET/CT imaging in response evaluation of patients with small cell lung cancerBarbara M Fischer, Jann Mortensen, Seppo W Langer, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PETMathias Loft, Camilla B Johnbeck, Esben A Carlsen, et al.
Acta Oncologica (Stockholm, Sweden)|September 15, 2023
Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomideAnnika Marie Ørting, Malene Martini Clausen, Patrick Soldath, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2024
Clinico-pathological characteristics and treatment outcome in non-small cell lung cancer in Greenland 2015-2020 - a comparison with the cohort from 2004 to 2010Dorte S Nørøxe, Simone Frandsen, Malene M Clausen, et al.
Surgical Oncology|March 1, 2022
Long-term outcomes after video-assisted thoracoscopic surgery in pulmonary large-cell neuroendocrine carcinomaPatrick Soldath, Tina Binderup, Frederik Carstensen, et al.
Molecular Pharmacology|April 19, 2002
Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibitionLars H Jensen, Axelle Renodon-Corniere, Irene Wessel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive ScansEsben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, et al.
Cancers|February 10, 2024
Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical CarcinoidsPatrick Soldath, Daniel Bianchi, Beatrice Manfredini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 24, 2016
Head-to-Head Comparison of <sup>64</sup>Cu-DOTATATE and <sup>68</sup>Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine TumorsCamilla B Johnbeck, Ulrich Knigge, Annika Loft, et al.
Pageof 12